(Q33168926)

English

Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1 reference

Europe PubMed Central

Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

essential hypertension

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Titmarsh S

1

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Monk JP

2

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

publication date

1 May 1987

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

461-477

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Pharmacology of terazosin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2885169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/2885169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative trials of terazosin with other antihypertensive agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/2885169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of renal insufficiency on the pharmacokinetics and pharmacodynamics of terazosin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2885169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of terazosin on serum lipids

1 reference

https://pubmed.ncbi.nlm.nih.gov/2885169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new prazosin analogue, Abbott-45975 (A-45975)

1 reference

https://pubmed.ncbi.nlm.nih.gov/2885169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overall safety of terazosin as an antihypertensive agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/2885169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of intravenous terazosin in hypertensive patients. A preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/2885169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Terazosin: an effective once-daily monotherapy for the treatment of hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/2885169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience with terazosin administered in combination with other antihypertensive agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/2885169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Terazosin kinetics after oral and intravenous doses

1 reference

https://pubmed.ncbi.nlm.nih.gov/2885169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of withdrawal of terazosin therapy in patients with hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/2885169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cumulative experience with terazosin administered in combination with diuretics

1 reference

https://pubmed.ncbi.nlm.nih.gov/2885169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term experience with terazosin for treatment of mild to moderate hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2885169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term BP monitoring in the evaluation of antihypertensive therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2885169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of terazosin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2885169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-198733050-00003

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33168926&oldid=2195128181"